Academic History

Martin Hutchings, MD, PhD, obtained his medical degree and PhD from the University of Copenhagen, Copenhagen, Denmark. Dr Hutchings is the head of service for Hodgkin lymphoma, mantle cell lymphoma, and Castleman’s disease and a staff specialist in the Department of Hematology at the Finsen Centre Laboratory of the Copenhagen University Hospital, Copenhagen, Denmark. 

Speaking on bispecific antibody treatment in patients with lymphoma

As well as treating patients with lymphoma, Dr Hutchings is a national principal investigator or sub-investigator in a variety of clinical trials investigating novel agents in solid and liquid malignancies. He has held the position of chairman of the Scientific Steering Committee for the EORTC Lymphoma Group since 2013 and co-authored both the international response criteria and guidelines for the use of imaging in lymphoma and the European Society of Medical Oncology (ESMO) guidelines for Hodgkin lymphoma and ’ultra high-risk’ lymphomas.